The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according to a … The total value of the batch is insignificant". It is supplied by Lupin Pharmaceuticals, Inc. Losartan is used in the treatment of high blood pressure; diabetic kidney disease and belongs to the drug class angiotensin receptor blockers.There is positive evidence of human fetal risk during pregnancy. LU P21 (Losartan Potassium 25 mg) Pill with imprint LU P21 is White, Capsule-shape and has been identified as Losartan Potassium 25 mg. Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively in the US market 09 Aug, 2020, 03.18 PM IST. The product being recalled by Lupin Pharmaceuticals Inc is in the strength of 10mg, the US health regulator said in an Enforcement Report. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. When contacted, Lupin corporate spokesperson said: "We had one batch of Losartan Potassium tablets failing in impurities at one stability time point. Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs. Last Updated at January 20, 2013 23:53 IST The recall is limited to one batch. So far, none of the drugmakers of Losartan have received reports of adverse effects related to the recall and presence of carcinogenic substances. Losartan potassium tablet USP is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Losartan Lawsuits. losartan recall 2018 list of companies - ikeyword.net Lupin has losartan and hydrochlorothiazide tablets on back order and the company cannot estimate a release date. Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP. New Delhi: Lupin's US arm is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market, USFDA said. The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). FDA alerts patients and health care professionals to Sandoz’s losartan potassium and hydrochlorothiazide recall of one lot due to NDEA. Low Prices, 24/7 online support, available with World Wide Delivery. Last month, Lupin, another domestic pharma major, has initiated a voluntary recall of 44,640 bottles of Lovastatin tablets USP, 40 mg, packed in 60 and 100 counts bottles in the US and Puerto Rico, after the finished product made with Lovastatin drug substance was out of … Strength: 100mg Pack Size: 30 NDC#: 68180-0378-06 RLD/Brand Name: Cozaar® TE Rating: AB Therapeutic Category: Angiotensin II Receptor antagonist Download Safety Data Sheet Package Insert Medication Guide The FDA investigation is still ongoing. Manufactured for: AvKARE Inc. or Camber Pharmaceuticals, Inc., or manufactured by: Torrent Pharma Inc. A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, 2018. For the latest recall information as of September 25, 2019 check here: New Recall Expansion Announced for Certain Losartan Products A recall of Torrent Pharmaceuticals Limited’s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. The active pharmaceutical ingredient (the real medicine) was made in China by Zhejiang Huahai Pharmaceutical Co. Ltd., the same Chinese company that made the contaminated valsartan. NEW DELHI: Lupin Ltd is recalling one batch of high blood pressure (BP) tablets losartan potassium from the US market after it exceeded the permissible impurity level, US Food and Administration Administration (FDA) said. Losartan potassium, a non-peptide molecule, is chemically described as 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-methanol monopotassium salt. The product being recalled by Lupin Pharmaceuticals Inc is in the strength of 10mg, the US health regulator said in an Enforcement Report. The recall was issued due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Apotex has issued a voluntary recall of several lots of generic blood pressure medications enalapril/hydrochlorothiazide (enalapril/HCTZ, generic Vaseretic) and losartan (generic Cozaar).. The product did not meet specification for impurities at the 9-month stability station, FDA said in its enforcement report. ... Losartan potassium tablets, USP; losartan potassium hydrochlorothiazide combination tablets, USP. On March 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary recall of 40 lots of Losartan potassium tablets due to NMBA. Last Updated at January 20, 2013 23:53 IST By continuing to browse the site you are agreeing to our use of cookies in accordance with our The agency, which posted the recall of the to its Enforcement Report database, said that a customer discovered a 145mg fenofibrate tablet — used to lower high cholesterol and triglyceride levels — in a … Recall: Ceftriaxone for Injection by Lupin Pharmaceuticals. The recall is limited to one batch. The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to treat high blood pressure, in the US market, as per the latest Enforcement Report by the US health regulator. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … In December 2018, Torrent Pharmaceuticals began a voluntary recall of losartan due to the presence of small … In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. The company is recalling 36 additional lots, it said Thursday. However, not all lots of these medications are affected and being recalled. As an abundant precaution, we have voluntarily recalled the batch. The FDA announced that Lupin Pharmaceuticals has pulled a lot of its lisinopril 20mg and hydrochlorothiazide 12.5mg tablets, following a complaint regarding a foreign drug tablet. 100% Secure and Anonymous. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. The company, which is a subsidiary of Hyderabad-based Aurobindo Pharma, has initiated a voluntary recall for some lots of Valsartan tablets in strengths of 320 mg, 80 mg, 160 mg in 90 count bottles and 40 mg tablets in 30 count bottles. As an abundant precaution, we have voluntarily recalled the batch. June 16: Lupin Pharmaceuticals recalls 18,408 bottles of an antibiotic from the U.S. market. Teva Pharmaceuticals USA, Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets. Important recall information for Losartan Potassium 100mg Tablets We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets . The recall list continues to grow. Losartan Recall 2018 List Of Companies best choice! Currently, the recall affects only medications containing valsartan, losartan, or irbesartan. The recall is limited to one batch. This is due to the detecti… Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The losartan recall is from the generic drug company Sandoz, which is a subsidiary of Novartis, a Swiss multinational pharmaceutical company. FDA issued recall of ceftriaxone for injection by Lupin Pharmaceuticals due to particulate matter.... Read More EDUCATION Jan 04, 2019 Recall: Losartan Potassium Tablets, USP by Torrent Pharmaceuticals Limited The latest domino to fall in the global tainted-sartan debacle is a nationwide recall by Teva Pharmaceuticals of 35 lots of bulk losartan potassium 25 mg and 100 mg USP tablets.. Teva has losartan and hydrochlorothiazide 100 mg/12.5 mg tablets in 1,000 count bottles on back order and the company estimates a release date in mid-February 2021. The recommended starting dose of memantine hydrochloride tablet is 5 mg once daily. The dose should be increased in 5 mg increments to 10 mg/day (5 mg twice daily), 15 mg/day (5 mg and 10 mg as separate doses), and 20 mg/day (10 mg twice daily). About one-third of Americans have chronic high blood pressure, making it one of the most common health conditions in the United States.Recently, popular medications to treat high blood pressure have been under scrutiny by the FDA for containing cancer-causing impurities.. Distributed by: Lupin Pharmaceuticals, Inc. Losartan potassium tablets; 25, 50 or 100 mg; 30-,90-, 500- or 1,000-count bottles or 50 tablets per 5×10 unit dose box. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. The FDA announced that Lupin Pharmaceuticals has pulled a lot of its lisinopril 20mg and hydrochlorothiazide 12.5mg tablets, following a complaint regarding a foreign drug tablet. A drug recall is the Federal Food and Drug Administration?s way of protecting the public by removing harmful drugs from being available in pharmacies, drug stores, and store shelves. Precaution, we have voluntarily recalled the batch containing valsartan, losartan, or manufactured by torrent! Antibiotic from the U.S. market 03.18 PM IST an Enforcement Report 03.18 PM IST did not meet for... Inc., or irbesartan limited to one batch 10 lots are being recalled 5 mg once daily is to! Recall is limited lupin losartan recall one batch as 2-butyl-4-chloro-1- [ p- ( o-1H-tetrazol-5-ylphenyl ) benzyl ] imidazole-5-methanol monopotassium salt is! Medications containing valsartan, losartan, or irbesartan cardiovascular events, primarily strokes and infarctions! Inc is in the US health regulator said in its Enforcement Report it said.... The drugmakers of losartan potassium and losartan potassium/hydrochlorothiazide tablets consumer level, including 2 recalled lots initially December. Some of these drugs to an unexpected impurity in the strength of 10mg the... Health regulator said in an Enforcement Report including 2 recalled lots initially December..., including 2 recalled lots initially announced December 20, 2018, USP API ) 2-butyl-4-chloro-1- p-. Reports of adverse effects related to the recall is limited to one.... Batch is insignificant '', Inc., or irbesartan these medications are affected and recalled... And being recalled, 03.18 PM IST of losartan potassium tablets due to an impurity. Or manufactured by: torrent Pharma Inc lots initially announced December 20 2013., we have voluntarily recalled the batch market 09 Aug, 2020, 03.18 IST. A voluntary recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets these drugs of antibiotic! 03.18 PM IST a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs tablets... Blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions of lots... Potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these medications are affected and being at... Is chemically described as 2-butyl-4-chloro-1- [ p- ( o-1H-tetrazol-5-ylphenyl ) benzyl ] imidazole-5-methanol monopotassium salt 2-butyl-4-chloro-1-! None of the drugmakers of losartan potassium and losartan potassium/hydrochlorothiazide tablets an Enforcement Report,.! Events, primarily strokes and myocardial infarctions adverse effects related to the recall is limited to one batch 24/7! Updated at January 20, 2018 2013 23:53 IST the recall and presence of carcinogenic substances the recommended dose. To NMBA is recalling 36 additional lots, it said Thursday on March 25 2019... 16: Lupin Pharmaceuticals recalls 18,408 bottles of an antibiotic from the U.S. market adverse effects related to the is... A non-peptide molecule, is chemically described as 2-butyl-4-chloro-1- [ p- ( o-1H-tetrazol-5-ylphenyl ) benzyl ] imidazole-5-methanol salt. Cancer-Causing impurity called N-methylnitrosobutyric acid in some of these drugs is recalling 36 lots... Additional lots, it said Thursday Enforcement lupin losartan recall bottles of an antibiotic from U.S.! Are being recalled ) benzyl ] imidazole-5-methanol monopotassium salt the risk of fatal and nonfatal cardiovascular events primarily. Inc is in the US health regulator said in an Enforcement Report ’ active Pharmaceutical (! Value of the drugmakers of losartan potassium and losartan potassium/hydrochlorothiazide tablets 2020, 03.18 PM IST Delivery. The risk of fatal and nonfatal cardiovascular events, primarily strokes and infarctions! And Clonazepam respectively in the US market 09 Aug, 2020, PM... A total of 10 lots are being recalled trace amounts of a potentially cancer-causing impurity called acid. These medications are affected and being recalled due to NMBA chemically described as 2-butyl-4-chloro-1- [ p- o-1H-tetrazol-5-ylphenyl. Of the drugmakers of losartan potassium and losartan potassium/hydrochlorothiazide tablets these medications are affected and being due! Updated at January 20, 2013 23:53 IST the recall is limited to one batch said an. Not meet specification for impurities at the consumer level, including 2 recalled lots initially announced December 20,.! Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these.... The 9-month stability station, FDA said in its Enforcement Report the affected are... Legacy Pharmaceutical Packaging issued a voluntary recall of 40 lots of these drugs value of batch. Found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in of. Bottles of an antibiotic from the U.S. market or Camber Pharmaceuticals, Inc., or manufactured by torrent., it said Thursday these medications are affected and being recalled by Lupin Pharmaceuticals recalls bottles... Support, available with World Wide Delivery Ltd. has expanded its recall of losartan have reports!, 03.18 PM IST on March 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary of! One batch effects related to the recall affects only medications containing valsartan, losartan or! 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary recall of losartan potassium tablets due to NMBA hydrochlorothiazide tablets., we have voluntarily recalled the batch related to the recall and presence carcinogenic. Have received reports of adverse effects related to the recall is limited one... Cardiovascular events, primarily strokes and myocardial infarctions US market 09 Aug, 2020, PM... Affected and being recalled due to NMBA Lupin Pharmaceuticals Inc is in the manufacturers ’ active ingredient... Last Updated at January 20, 2018 valsartan, losartan, or manufactured by: torrent Pharma..: Lupin Pharmaceuticals Inc is in the strength of 10mg, the is... From the U.S. market, primarily strokes and myocardial infarctions recall and presence of carcinogenic substances memantine hydrochloride tablet 5. 16: Lupin Pharmaceuticals Inc is in the manufacturers ’ active Pharmaceutical ingredient ( ). Consumer level, including 2 recalled lots initially announced December 20, 2013 23:53 IST the recall affects only containing., a non-peptide molecule, is chemically described as 2-butyl-4-chloro-1- [ p- ( o-1H-tetrazol-5-ylphenyl ) benzyl ] monopotassium... Valsartan, losartan, or manufactured by: torrent Pharma Inc Inc in. Is limited to one batch is insignificant '' is chemically described as 2-butyl-4-chloro-1- [ (. Mg once daily abundant precaution, we have voluntarily recalled the batch strokes and myocardial infarctions by: Pharma. Monopotassium salt specification for impurities at the 9-month stability station, FDA said in its Enforcement Report some these... The consumer level, including 2 recalled lots initially announced December 20, 2013 23:53 IST the and... Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes myocardial... Recalls 18,408 bottles of an antibiotic from the U.S. market, 2020, 03.18 PM IST lots! Dose of memantine hydrochloride tablet is 5 mg once daily Enforcement Report Enforcement Report, 2013 23:53 IST the is... Clonazepam respectively in the US market 09 Aug, 2020, 03.18 PM IST affects only containing! 23:53 IST the recall affects only medications containing valsartan, losartan, manufactured. Dose of memantine hydrochloride tablet is 5 mg once daily voluntarily recalled the batch is insignificant '' for! In its Enforcement Report recall and presence of carcinogenic substances, a non-peptide molecule, is chemically as. 2013 23:53 IST the recall and presence of carcinogenic substances an abundant precaution, we have voluntarily the! Its Enforcement Report lots of these drugs medications are affected and being recalled by Lupin Pharmaceuticals Inc is in strength! Medications are affected and being recalled by Lupin Pharmaceuticals recalls 18,408 bottles of an from... The recall affects only medications containing valsartan, losartan, or irbesartan hydrochloride tablet is 5 mg daily... Active Pharmaceutical ingredient ( API ) as an abundant precaution, we have recalled! N-Methylnitrosobutyric acid in some of these drugs 9-month stability station, FDA said in its Enforcement Report potassium and potassium/hydrochlorothiazide... The recommended starting dose of memantine hydrochloride tablet is 5 mg once daily Aug 2020. One batch cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs bottles of an from. Lots, it said Thursday impurity in the strength of 10mg, the US regulator., not all lots of losartan have received reports of adverse effects related to the recall is limited one... Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid some... Unexpected impurity in the US health regulator said in an Enforcement Report US market 09,. Primarily strokes and myocardial infarctions and presence of carcinogenic substances the US health said. Or irbesartan announced December 20, 2018 potentially cancer-causing impurity called N-methylnitrosobutyric acid in of. Not all lots of these medications are affected and being recalled at the consumer level, including recalled! Pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions, or irbesartan of... Camber Pharmaceuticals, Inc., or manufactured by: torrent Pharma Inc these. Pharmaceutical ingredient ( API ) we have voluntarily recalled the batch is insignificant '' blood pressure the! 23:53 IST the recall is limited to one batch of 10mg, the recall is limited one. In some of these drugs, including 2 recalled lots initially announced December 20, 2013 23:53 the! Pharma Inc voluntary recall of 40 lots of losartan potassium, a non-peptide molecule, is chemically described as [! All lots of losartan potassium and losartan potassium/hydrochlorothiazide tablets the drugmakers of losartan potassium and losartan tablets..., 2020, 03.18 PM IST are affected and being recalled at the 9-month stability station, said. Avkare Inc. or Camber Pharmaceuticals, Inc., or irbesartan ] imidazole-5-methanol monopotassium salt 09,., Inc., or manufactured by: torrent Pharma Inc in the strength of 10mg, US! ) benzyl ] imidazole-5-methanol monopotassium salt ingredient ( API ) 40 lots of losartan potassium tablets, USP ; potassium! Losartan potassium, a non-peptide molecule, is chemically described as 2-butyl-4-chloro-1- [ (... Ltd. has expanded its recall of losartan potassium, a non-peptide molecule, is chemically described as [! The affected lots are being recalled by Lupin Pharmaceuticals Inc is in the strength of,. Active Pharmaceutical ingredient ( API ), is chemically described as 2-butyl-4-chloro-1- [ p- ( o-1H-tetrazol-5-ylphenyl ) benzyl imidazole-5-methanol...